Group 6 Copy 531
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can a rabies vaccination booster save African Wild Dogs?

    Rabies is one of the greatest threats to the continued survival of the African wild dog (Lycaon pictus...

    Eco-friendly and affordable molecular weaponry against snails that transmit schistosomiasis

    Schistosomiasis is a disease transmitted by snails, responsible for chronic illness of many millions of...

    Detection of Zika virus rapidly without the need for a laboratory in Brazil

    Zika (PORTUGUESE) is a rapidly emerging pandemic, a global health emergency. ZIKV has been associated with...

    Backer Badge Funded